Minutes QRPH July 22-25 2008 Meeting: Difference between revisions
Jump to navigation
Jump to search
FEisenberg (talk | contribs) New page: == Agenda (Minutes) QRPH Technical Committee Meeting == ===July 22-25 2008=== Attendees Floyd Eisenberg, Siemens Healthcare (Co-chair) Jason Colquitt, Greenway Medical Systems (Co-ch... |
FEisenberg (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
== Agenda (Minutes) QRPH Technical Committee Meeting == | == Agenda (Minutes) QRPH Technical Committee Meeting == | ||
===July 22-25 2008=== | ===July 22-25 2008=== | ||
| Line 17: | Line 16: | ||
== Quality Measure Value Set White Paper == | == Quality Measure Value Set White Paper == | ||
* Comments and resolution: [ftp://ftp.ihe.net/Quality/2008_2009_YR_2/Technical/ihe_qrph_public_comment_July_2008%5B1%5D[1].doc Comments and resolution] | |||
* Clean version: [ftp://ftp.ihe.net/Quality/2008_2009_YR_2/Technical/CLEAN%20IHE_QRPH_Whitepaper_Perfomance_Measure_Data_Element_Structured_for_EHR_Extraction_2008-07-22_Comment_resolution.doc White Paper] | |||
* Track changes version: [ftp://ftp.ihe.net/Quality/2008_2009_YR_2/Technical/COMMENT%20IHE_QRPH_Whitepaper_Perfomance_Measure_Data_Element_Structured_for_EHR_Extraction_2008-07-22_Comment_resolution.doc Track Changes Version] | |||
== Clinical Research Data Capture Profile == | == Clinical Research Data Capture Profile == | ||
Comment Resolution | Comment Resolution | ||
Revision as of 13:15, 23 July 2008
Agenda (Minutes) QRPH Technical Committee Meeting
July 22-25 2008
Attendees
Floyd Eisenberg, Siemens Healthcare (Co-chair) Jason Colquitt, Greenway Medical Systems (Co-chair) Ana Estelrich, DIP, GMP (Planning Committee Co-Chair) Landen Bain, CDISC Patty Craig, The Joint Commission Thomas Kuhn, ACP Shirley Neal, Misys Jacob Reider, Misys Mick Talley, University Bank Gary Walker, Quintiles
Quality Measure Value Set White Paper
- Comments and resolution: [1.doc Comments and resolution]
- Clean version: White Paper
- Track changes version: Track Changes Version
Clinical Research Data Capture Profile
Comment Resolution
- Active Version in Comment Resolution
- Signature requirements for Pre-clinical and Clinical Study Reports (Comment from Rich Furr, SafeBioPharma)
- Pre-clinical and clinical study reports generally require multiple signatures prior to inclusion in a dossier that will be submitted in support of a new drug application (FDA) or marketing authorization application (EU).
- Such requirements are defined in both US and EU regulatory documents that implement the ICH E3 requirements for Structure and Content of Clinical Study Reports, as follows:
- “Where signatures of the principal or coordinating investigators are required by regulatory authorities, these should be included in appendix 16.1.5 (see Annex II for a sample form). Where these are not required, the signature of the sponsor’s responsible medical officer should be provided in appendix 16.1.5.”
- In fact, in many cases, such reports include multiple signatures which may include study authors, sponsor reviewers and, finally, sponsor approvers. All such signatures could be applied using digital signature functionality to provide both non-repudiation and long-term signature persistence. The use of simple electronic signatures does NOT provide such capabilities and would not support long-term audit/inspection requirements.
- Further, ICH Good Clinical Practices identify other documents, e.g., electronic case report forms (eCRF), eCRF correction sheets, also require signatures which may be applied using digital certificates to provide the same strength as cited above.
- In each of these instances, we believe the digital signatures applied to the CDISC ODM could provide the needed support.
Digital Signature Suggested Content